ST-elevation myocardial infarction after thrombolytic therapy with Tenecteplase for acute ischaemic stroke.
Jorge Enrique SinclairMarie PlanteMichael F HarrisonDevang K SanghaviPublished in: BMJ case reports (2023)
Myocardial infarction (MI) secondary to thrombolytic therapy in the setting of acute ischaemic stroke (AIS) is a rare but severe complication. This phenomenon has been well documented in the past with recombinant tissue-type plasminogen activator, also known as Alteplase. However, there are no documented reports of MI secondary to Tenecteplase (TNKase), an alternative thrombolytic agent rapidly gaining favour in managing AIS. We report a male patient in his 50s who received TNKase for an AIS and subsequently developed an inferolateral ST elevation MI.
Keyphrases
- st elevation myocardial infarction
- acute ischemic stroke
- pulmonary embolism
- liver failure
- respiratory failure
- percutaneous coronary intervention
- drug induced
- aortic dissection
- heart failure
- hepatitis b virus
- left ventricular
- case report
- early onset
- coronary artery disease
- stem cells
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome